Bristol-Myers Squibb
BMY
#183
Rank
NZ$202.88 B
Marketcap
NZ$99.37
Share price
-2.95%
Change (1 day)
18.59%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.96

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$5.85. an increase over its 2024 EPS that were of NZ-$7.47.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025NZ$5.83-178.05%
2024NZ-$7.47-213.92%
2023NZ$6.5630.2%
2022NZ$5.04-6.04%
2021NZ$5.36-179.29%
2020NZ-$6.76-281%
2019NZ$3.73-27.06%
2018NZ$5.12
2016NZ$4.51175.26%
2015NZ$1.64-19.83%
2014NZ$2.04-22.44%
2013NZ$2.6434.48%
2012NZ$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.82 221.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.17 108.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.30-60.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.04-30.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.91 565.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.21 314.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.49-40.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$14.92 155.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.35 111.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.02 71.39%๐Ÿ‡ฌ๐Ÿ‡ง UK